These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23315232)

  • 1. Liquid formulations for long-term storage of monoclonal IgGs.
    Mueller M; Loh MQ; Tee DH; Yang Y; Jungbauer A
    Appl Biochem Biotechnol; 2013 Feb; 169(4):1431-48. PubMed ID: 23315232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid formulations for stabilizing IgMs during physical stress and long-term storage.
    Mueller M; Loh MQ; Tscheliessnig R; Tee DH; Tan E; Bardor M; Jungbauer A
    Pharm Res; 2013 Mar; 30(3):735-50. PubMed ID: 23143394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Freeze-dried snake antivenoms formulated with sorbitol, sucrose or mannitol: comparison of their stability in an accelerated test.
    Herrera M; Tattini V; Pitombo RN; Gutiérrez JM; Borgognoni C; Vega-Baudrit J; Solera F; Cerdas M; Segura A; Villalta M; Vargas M; León G
    Toxicon; 2014 Nov; 90():56-63. PubMed ID: 25091348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
    Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
    Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
    Szenczi A; Kardos J; Medgyesi GA; Závodszky P
    Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
    Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
    MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of thermal treatment on the stability of freeze-dried amorphous pharmaceuticals: II. Aggregation in an IgG1 fusion protein.
    Wang B; Cicerone MT; Aso Y; Pikal MJ
    J Pharm Sci; 2010 Feb; 99(2):683-700. PubMed ID: 19798764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of etanercept stability as exposed to various sugars with biophysical assessment.
    Lim DG; Kim NA; Lim JY; Kim KH; Hada S; Jeong SH
    Int J Pharm; 2014 Dec; 476(1-2):50-9. PubMed ID: 25269011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sorbitol crystallization can lead to protein aggregation in frozen protein formulations.
    Piedmonte DM; Summers C; McAuley A; Karamujic L; Ratnaswamy G
    Pharm Res; 2007 Jan; 24(1):136-46. PubMed ID: 17109212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of hanging drop technique to optimize human IgG formulations.
    Li G; Kasha PC; Late S; Banga AK
    J Pharm Pharmacol; 2010 Jan; 62(1):125-31. PubMed ID: 20723008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Proline reduces IgG dimer content and enhances the stability of intravenous immunoglobulin (IVIG) solutions.
    Bolli R; Woodtli K; Bärtschi M; Höfferer L; Lerch P
    Biologicals; 2010 Jan; 38(1):150-7. PubMed ID: 19931468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A broad range of Fab stabilities within a host of therapeutic IgGs.
    Garber E; Demarest SJ
    Biochem Biophys Res Commun; 2007 Apr; 355(3):751-7. PubMed ID: 17321501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.
    Kasper JC; Schaffert D; Ogris M; Wagner E; Friess W
    J Control Release; 2011 May; 151(3):246-55. PubMed ID: 21223985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of IgG kinetic stability by differential scanning calorimetry, probe fluorescence and light scattering.
    Nemergut M; Žoldák G; Schaefer JV; Kast F; Miškovský P; Plückthun A; Sedlák E
    Protein Sci; 2017 Nov; 26(11):2229-2239. PubMed ID: 28833802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive evaluation of etanercept stability in various concentrations with biophysical assessment.
    Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
    Int J Pharm; 2014 Jan; 460(1-2):108-18. PubMed ID: 24269208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced analyses of kinetic stabilities of iggs modified by mutations and glycosylation.
    Sedlák E; Schaefer JV; Marek J; Gimeson P; Plückthun A
    Protein Sci; 2015 Jul; 24(7):1100-13. PubMed ID: 25966898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sucrose hydrolysis on the stability of protein therapeutics during accelerated formulation studies.
    Banks DD; Hambly DM; Scavezze JL; Siska CC; Stackhouse NL; Gadgil HS
    J Pharm Sci; 2009 Dec; 98(12):4501-10. PubMed ID: 19388069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody.
    Wakankar AA; Liu J; Vandervelde D; Wang YJ; Shire SJ; Borchardt RT
    J Pharm Sci; 2007 Jul; 96(7):1708-18. PubMed ID: 17238195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Stable IgG Formulation Containing Amino Acids and Trehalose During Freeze-Drying and After Storage: a Central Composite Design.
    Mirfakhraei Y; Faghihi H; Zade AHM; Darabi M; Vatanara A
    AAPS PharmSciTech; 2019 Mar; 20(4):154. PubMed ID: 30919164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.